Position in AZN
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$59,540
New position
Shares Held
314
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,275
of 1,459 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HIGHLINE WEALTH PARTNERS LLC holds $1,353,065 across 14 Drug Manufacturers - General names. AZN ranks #6 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,635 | $415,240 | |
| 2 | LLY |
ELI LILLY & Co
|
180 | $215,897 | |
| 3 | AMGN |
Amgen Inc
|
429 | $155,349 | |
| 4 | MRK |
Merck & Co., Inc.
|
932 | $119,762 | |
| 5 | ABBV |
AbbVie Inc.
|
419 | $105,437 | |
| 6 | AZN |
Astrazeneca PLC
This page
|
314 | $59,540 | |
| 7 | PFE |
Pfizer Inc
|
2,356 | $56,732 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
446 | $56,347 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $59,540 | 314 | Shares | Sole | 2026-07-15 | |
| No filing history on record for this holder in this stock. | ||||||